Alpha Cells are a type of endocrine cell found in the pancreas, specifically in the islets of Langerhans. These cells are responsible for producing and releasing the hormone glucagon. Glucagon plays a crucial role in glucose homeostasis by stimulating the liver to convert stored glycogen into glucose, which is then released into the bloodstream. In response to low blood glucose levels, alpha cells are activated to release glucagon, promoting the breakdown of glycogen into glucose. This process raises blood sugar levels, providing a vital energy source for the body. The regulation of blood glucose is intricately balanced with insulin, another hormone produced by beta cells in the pancreas, ensuring stable glucose levels. Alpha cells are essential components of the pancreatic endocrine system and contribute to the body's overall metabolic regulation. Dysfunction in alpha cell activity can lead to imbalances in blood glucose levels, contributing to conditions such as diabetes mellitus. Research on alpha cells is critical for understanding the complex interplay between different pancreatic cell types and developing targeted therapies for metabolic disorders. Advances in this field contribute to our knowledge of glucose metabolism and potential interventions for conditions related to insulin and glucagon dysregulation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy